Cardinal Health Pharmaceutical and Specialty Solutions — Percent of Gross Trade Receivables increased by 18.2% to 26.0% in Q2 2025 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may signal potential credit risk or slower payment cycles, while a decrease suggests improved liquidity and faster cash conversion.
This metric measures the portion of total gross trade receivables attributed to specific customer segments or entities w...
Comparable to 'Accounts Receivable Concentration' metrics found in the financial disclosures of large-scale healthcare distributors.
cah_segment_pharmaceutical_and_specialty_solutions_percent_of_gross_trade_receivables| Q2 '23 | Q2 '24 | Q2 '25 | |
|---|---|---|---|
| Value | 23% | 22% | 26% |
| QoQ Change | — | -4.3% | +18.2% |
| YoY Change | — | -4.3% | +18.2% |